Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Sheehan

Showing results (91-100 of 195) with videos related to

Pageof 20
Sort By:
The Medical Journal of Australia|May 7, 2013
Injuries to the head and face sustained while surfboard ridingSimon J Dimmick, Patrick V Sheehan, Mark Gillett, et al.
Psychopharmacology Bulletin|November 17, 2007
An open-label study of tiagabine in panic disorderDavid V Sheehan, Kathy Harnett Sheehan, B Ashok Raj, et al.
The American Journal of Psychiatry|June 1, 2000
Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorderK Rickels, M H Pollack, D V Sheehan, et al.
Scientific Reports|December 29, 2019
A simple mooring modification reduces impacts on seagrass meadowsAnna L Luff, Emma V Sheehan, Mark Parry, et al.
The Journal of Clinical Psychiatry|January 27, 2005
Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorderDavid V Sheehan, Daniel B Burnham, Malini K Iyengar, et al.
International Clinical Psychopharmacology|February 25, 2009
Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic featuresDavid V Sheehan, Charles B Nemeroff, Michael E Thase, et al.
Headache|May 1, 1986
A combination drug treatment for acute common migraineE Uzogara, D V Sheehan, T C Manschreck, et al.
The American Journal of Managed Care|October 21, 2005
Differences in total medical costs across the SSRIs for the treatment of depression and anxietyDavid V Sheehan, Michael T Eaddy, Manan B Shah, et al.
Journal of Affective Disorders|April 2, 2017
Restoring function in major depressive disorder: A systematic reviewDavid V Sheehan, Kazuyuki Nakagome, Yuko Asami, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 18, 2012
Vortioxetine (Lu AA21004) in generalized anxiety disorder: results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trialLeszek Bidzan, Atul R Mahableshwarkar, Paula Jacobsen, et al.
Pageof 20

Showing results (91-100 of 195) with videos related to

Sort By:
Pageof 20
The Medical Journal of Australia|May 7, 2013
Injuries to the head and face sustained while surfboard ridingSimon J Dimmick, Patrick V Sheehan, Mark Gillett, et al.
Psychopharmacology Bulletin|November 17, 2007
An open-label study of tiagabine in panic disorderDavid V Sheehan, Kathy Harnett Sheehan, B Ashok Raj, et al.
The American Journal of Psychiatry|June 1, 2000
Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorderK Rickels, M H Pollack, D V Sheehan, et al.
Scientific Reports|December 29, 2019
A simple mooring modification reduces impacts on seagrass meadowsAnna L Luff, Emma V Sheehan, Mark Parry, et al.
The Journal of Clinical Psychiatry|January 27, 2005
Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorderDavid V Sheehan, Daniel B Burnham, Malini K Iyengar, et al.
International Clinical Psychopharmacology|February 25, 2009
Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic featuresDavid V Sheehan, Charles B Nemeroff, Michael E Thase, et al.
Headache|May 1, 1986
A combination drug treatment for acute common migraineE Uzogara, D V Sheehan, T C Manschreck, et al.
The American Journal of Managed Care|October 21, 2005
Differences in total medical costs across the SSRIs for the treatment of depression and anxietyDavid V Sheehan, Michael T Eaddy, Manan B Shah, et al.
Journal of Affective Disorders|April 2, 2017
Restoring function in major depressive disorder: A systematic reviewDavid V Sheehan, Kazuyuki Nakagome, Yuko Asami, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 18, 2012
Vortioxetine (Lu AA21004) in generalized anxiety disorder: results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trialLeszek Bidzan, Atul R Mahableshwarkar, Paula Jacobsen, et al.
Pageof 20